Clinical Trial Update: Myocardial Fibrosis Identification in Patients With Anthracycline-induced Cardiotoxicity [NA]

View source ↗

Summary

A clinical trial evaluating myocardial fibrosis identification in patients with anthracycline-induced cardiotoxicity; current status is unknown and phase is not…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anthracycline-induced Cardiotoxicity
• Cardiomyopathy

Snippet

Sponsor: European Institute of Oncology | Conditions: Cardiomyopathy Due to Drug | NA | Status: UNKNOWN